Company Profiles

driven by the PitchBook Platform

Light Sciences Oncology

Description

Developer of light-activated drug products to treat patients with solid tumor cancers. The company's products include Aptocine, a light-activated and water-soluble drug with a disposable drug activator for use by physicians for the treatment of solid tumors, as well as other indications, such as benign prostatic hyperplasia.

1994

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$350k

Latest Deal Amount

$193M

Total Amount Raised

Description

Developer of light-activated drug products to treat patients with solid tumor cancers. The company's products include Aptocine, a light-activated and water-soluble drug with a disposable drug activator for use by physicians for the treatment of solid tumors, as well as other indications, such as benign prostatic hyperplasia.

Website:

www.lsoncology.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Pharmaceuticals and Biotechnology

Primary Office

12600 Southeast 38th Street Suite 111 Bellevue, WA 98006United States +1 (425) 957-8900
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Light Sciences Oncology's full profile, request a free trial.

Light Sciences Oncology Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Light Sciences Oncology Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Light Sciences Oncology Investors (15)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Adams Street PartnersPE/BuyoutMinority000 0000000 0000
Burrill & CoMerchant Banking FirmMinority000 0000000 0000
China Development Industrial BankVenture CapitalMinority000 0000000 0000
Deephaven Capital ManagementVenture CapitalMinority000 0000000 0000
Essex WoodlandsGrowth/ExpansionMinority000 0000000 0000
Adams Street Partners PE/Buyout
Burrill & Co Merchant Banking Firm
China Development Industrial Bank Venture Capital
Deephaven Capital Management Venture Capital
Essex Woodlands Growth/Expansion

Light Sciences Oncology Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Jim ChenChief Strategy Officer
Carol SchaafChief Revenue Officer & CRA
Richard GravesDirector, Information Technology
Susan SpraitzarSenior Director, Regulatory Affairs
Steven DalySenior Director, Strategy and Business Development
Jim Chen Chief Strategy Officer
Carol Schaaf Chief Revenue Officer & CRA
Richard Graves Director, Information Technology
Susan Spraitzar Senior Director, Regulatory Affairs
Steven Daly Senior Director, Strategy and Business Development

Light Sciences Oncology Board Members (8)

NameRepresentingRoleSinceContact
Info
Akbar SeddighSelfBoard Member000 0000
David HolveckSelfBoard Member000 0000
Dennis Langer MDSelfBoard Member000 0000
Jeffrey Himawan Ph.DEssex WoodlandsBoard Member000 0000
Martin OlinSelfBoard Member000 0000
Akbar Seddigh Board Member Self
David Holveck Board Member Self
Dennis Langer MD Board Member Self
Jeffrey Himawan Ph.D Board Member Essex Woodlands
Martin Olin Board Member Self
Request full access to PitchBook